A Phase 1, First-in-human Study of MORF-440 (LY4292009) in Healthy Participants
Clinical trial NCT06977880 · COMPLETED
Trial details
- NCT number
- NCT06977880
- Sponsor
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-19
- Primary completion
- 2026-03-20
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.